Medical Aid in Dying: What Oncology Providers Need to Know
Data suggest that most patients who use medical aid in dying (MAID) have cancer, but some oncology providers do not feel well informed about MAID.
Chronic Myeloid Leukemia
CHRONIC MYELOID LEUKEMIA ADVISOR
FEATURED CONTENT
-
-
Rising Costs of Oral Anticancer Drugs Burden Medicare Recipients; New Law May Provide Some Relief
New data highlight the high cost of targeted oral anticancer medicines for patients with Medicare Part D coverage. -
Two-Step Strategy Promising in TKI Dose Reduction in Chronic Myeloid Leukemia
The likelihood of recovery of major molecular response after resuming TKI therapy at reduced doses was 86%. -
Guidelines for CML Not Followed in the Real World
“Excellent” overall survival is achievable with currently available drugs, according to researchers. -
Quicker FDA Approval of Cancer Drugs Not Tied to Clinical Benefit
The FDA tends to approve cancer drugs faster than other agencies, but there is no link between faster review and high clinical benefit.
CHRONIC MYELOID LEUKEMIA NEWS
Olverembatinib Shows Promise in TKI-Resistant CML and Ph+ ALL
Asciminib Shows Early Promise as Frontline Therapy for CML-CP
Tyrosine Kinase Inhibitor Discontinuation Safe in Pediatric Chronic Myeloid Leukemia
Illegitimate Online Pharmacies May Put Cancer Patients at Risk
Asciminib Continues to Demonstrate Superior Efficacy for CML-CP
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Chronic Myeloid Leukemia
Loading... 
Loading...